Purple Biotech shares are trading lower by 11.5% during Monday's session. The company announced the exercise of warrants for $2 million gross proceeds. Unlock your all-in-one trading dashboard with ...

On May 30, Emily Bodnar, an analyst at H.C. Wainwright, raised her price target for Purple Biotech Ltd. (NASDAQ:PPBT) from $33 to $34 while keeping her Buy rating on the PPBT stock. The change comes ...

Purple Biotech Ltd. Sponsored ADR (PPBT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

On Monday, Purple Biotech Ltd (NASDAQ:PPBT) reported the final results from the randomized Phase 2 study of its lead oncology drug, CM24, a humanized monoclonal antibody that blocks CEACAM1, in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Purple Biotech ( (PPBT)) has shared an ...

Purple Biotech ( (PPBT)) just unveiled an update. On November 14, 2025, Purple Biotech announced its third-quarter financial results and business update. The company highlighted the development of its ...

Purple Biotech Ltd. ADR Annual cash flow by MarketWatch. View PPBT net cash flow, operating cash flow, operating expenses and cash dividends.